Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages
Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy
Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy
View: Text | PDF
Research Article Infectious disease Inflammation

EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages

  • Text
  • PDF
Abstract

Alveolar macrophages (AMs) act as gatekeepers of the lung’s immune responses, serving essential roles in recognizing and eliminating pathogens. The transcription factor (TF) early growth response 2 (EGR2) has been recently described as required for mature AMs in mice; however, its mechanisms of action have not been explored. Here, we identified EGR2 as an epigenomic regulator and likely direct proximal transcriptional activator in AMs using epigenomic approaches (RNA sequencing, ATAC sequencing, and CUT&RUN). The predicted direct proximal targets of EGR2 included a subset of AM identity genes and ones related to pathogen recognition, phagosome maturation, and adhesion, such as Clec7a, Atp6v0d2, Itgb2, Rhoc, and Tmsb10. We provided evidence that EGR2 deficiency led to impaired zymosan internalization and reduced the capacity to respond to Aspergillus fumigatus. Mechanistically, the lack of EGR2 altered the transcriptional response, secreted cytokines (i.e., CXCL11), and inflammation-resolving lipid mediators (i.e., RvE1) of AMs during in vivo zymosan-induced inflammation, which manifested in impaired resolution. Our findings demonstrated that EGR2 is a key proximal transcriptional activator and epigenomic bookmark in AMs responsible for select, distinct components of cell identity and a protective transcriptional and epigenomic program against fungi.

Authors

Zsuzsanna Kolostyak, Dora Bojcsuk, Viktoria Baksa, Zsuzsa Mathene Szigeti, Krisztian Bene, Zsolt Czimmerer, Pal Boto, Lina Fadel, Szilard Poliska, Laszlo Halasz, Petros Tzerpos, Wilhelm K. Berger, Andres Villabona-Rueda, Zsofia Varga, Tunde Kovacs, Andreas Patsalos, Attila Pap, Gyorgy Vamosi, Peter Bai, Balazs Dezso, Matthew Spite, Franco R. D’Alessio, Istvan Szatmari, Laszlo Nagy

×

Figure 1

Changing chromatin accessibility reveals the role of EGR2 in epigenomic regulation of AMs.

Options: View larger image (or click on image) Download as PowerPoint
Changing chromatin accessibility reveals the role of EGR2 in epigenomic ...
(A) Heatmap representation of single-cell-derived (ref. 37; Cohen et al., 2018; GSE119228) average gene expression values (z score) of AM-specific TFs and Pparg (ref. 11; Gautier et al., 2012) in fetal monocytes (Fetal Mo), pre-AMs (Pre AM), and mature AMs (Mature AM). (B) The volcano plot depicts the differentially opening (n = 4,792), closing (n = 1,906), and unchanged (n = 64,165) chromatin regions between Egr2+/+ and Egr2fl/fl AMs determined by ATAC-Seq. (C) The violin plots visualize the average coverage (reads per kilobase of transcript, per million mapped reads; RPKM) values of the closing (green) and opening (yellow) DARs and unchanged (gray) chromatin regions between Egr2+/+ versus Egr2fl/fl AMs (paired t test, P ≤ 0.05) at the promoter and enhancer regions. (D) The stacked bar chart represents the genomic distribution of DARs and unchanged chromatin regions between Egr2+/+ versus Egr2fl/fl AMs (TSS, transcription start site; 3′ UTR, 3′ untranslated region; promoter-TSS, both TSS –1,000 bp/+100 bp and 5′ UTRs; intergenic, both intergenic and noncoding regions). (E) De novo motif enrichment of differentially closing (green) and opening (orange) chromatin regions for Egr2+/+ versus Egr2fl/fl AMs. The significantly enriched motif matrices are presented along with the P value rank in the analysis, and the target% values are indicated in parentheses. (F) Read distribution heatmap shows the chromatin openness of the closing and opening DARs and unchanged chromatin regions in Egr2+/+ and Egr2fl/fl AMs (2 kbp frames relative to the summit). Motif distribution heatmaps show the presence of indicated TF binding motifs (2 kbp frame relative to the summit). (G) Box plots show the motif scores of EGR, C/EBP, PU.1, and AP-1 motifs calculated on the opened DARs and unchanged chromatin regions (paired t test, P ≤ 0.05).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts